Knowledge Library
AACR 2025 Posters: Sneak Peek
From April 25 to 30, 2025, the annual meeting of the American Association for Cancer Research (AACR), one of the largest and longest-standing cancer research conferences in the world, will be held in Chicago. At this year’s AACR meeting, WuXi Biology has been selected to present several posters detailing latest scientific insights, covering a range …Read More >
Poster Presentations at AACR 2025
At this year’s annual meeting of the American Association for Cancer Research (AACR), WuXi Biology has been selected to present multiple posters detailing latest scientific insights, covering a range of cutting-edge topics from preclinical tumor model development and biomarker discovery, to the evaluation of novel anti-cancer therapies. Explore this quick overview of WuXi Biology’s pioneering …Read More >
Advancements in Membranous Nephropathy
From Pathogenesis to Therapeutic Innovations Introduction: Membranous nephropathy (MN) has received particular attention among autoimmune kidney disease due to its distinct pathophysiology and clinical manifestations. Unlike other autoimmune nephropathies, MN is primarily driven by pathogenic autoantibodies that activate immune cells, leading to oxidative stress and inflammatory responses that compromise the glomerular filtration barrier [1, 2]. …Read More >
Sclerosis and Fibrosis Disease Models
Systemic sclerosis (also known as scleroderma) is a chronic autoimmune disease that leads to the buildup of scar tissue in various internal organs, as well as the skin. Fibrosis is a key feature of systemic sclerosis, where uncontrolled production of collagen and other extracellular matrix proteins by fibroblasts leads to excess connective tissue accumulation. This …Read More >
Synthetic Lethality Related Tumor Models
Synthetic lethality, where combining two non-lethal mutations results in cell death, is exploited in cancer therapy, with PARP inhibitors like olaparib targeting BRCA-deficient cells by exploiting this interaction. Werner syndrome helicase (WRN) is a synthetic lethal target in cancers with microsatellite instability due to impaired DNA mismatch repair. WRN is synthetically lethal with MLH1, a …Read More >
Polycythemia Vera Disease Mouse Models
Polycythemia vera (PV) is a chronic myeloproliferative disorder, a type of blood cancer characterized by the overproduction of red blood cells (erythrocytosis) which can lead to thicker blood and an increased risk of blood clot. Most cases of PV are caused by a point mutation in the JAK2 gene (JAK2-V617F). To support drug discovery teams …Read More >
Platform Supporting the Discovery of Agents against HSV
Herpes simplex virus 1 and 2 (HSV-1 and HSV-2) are globally prevalent human pathogens associated with a wide range of diseases, from mild conditions such as herpes labialis (cold sores) to serious infections such as encephalitis and meningitis. HSV can establish a lifelong latent infection in neurons of the peripheral nervous system and can reactivate …Read More >
Epilepsy Animal Models
Epilepsy is a chronic brain disorder characterized by recurring seizures, which are episodes of uncontrolled and abnormal electrical activity in the brain that can cause changes in behavior, sensations, awareness, and movement. Epilepsy has a wide range of consequences, impacting neurobiology, cognition, and psychosocial well-being. To support drug discovery teams focused on epilepsy research, our …Read More >
Rare Neurological Disease Animal Models
Rare neurological diseases are conditions affecting the nervous system that occur infrequently, with examples including Huntington’s disease, Rett syndrome, and Amyotrophic Lateral Sclerosis (ALS). These rare disorders can be classified into various categories based on the affected systems/organs, among which, neuroinflammatory & neuroimmunology-related disorders, movement disorders, and motor neuron disease show higher prevalence. To support …Read More >